Biotech · Private company · San Diego, CA, US
Blacksmith Medicines, Inc.
Track this companyFree. Adds Blacksmith Medicines, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Combination of a novel selective FEN1 metallonuclease inhibitor with Olaparib for the treatment of PARP-resistant ovarian cancersFiscal year 2026 · $399.9KNIH RePORTER 1R43CA309911-01A1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious DiseasesFiscal year 2026 · $970.7KNIH RePORTER 75N93022C00060-P00015-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious DiseasesFiscal year 2024 · $6.3MNIH RePORTER 75N93022C00060-P00003-9999-1 · fetched Nov 12, 2026